TimeScale Financial’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$650 Buy
55
+1
+2% +$11 ﹤0.01% 563
2023
Q1
$619 Buy
54
+3
+6% +$37 ﹤0.01% 554
2022
Q4
$673 Hold
51
﹤0.01% 527
2022
Q3
$1K Buy
51
+1
+2% +$15 ﹤0.01% 521
2022
Q2
$1K Buy
50
+1
+2% +$13 ﹤0.01% 491
2022
Q1
$1K Buy
49
+1
+2% +$14 ﹤0.01% 504
2021
Q4
$1K Buy
48
+1
+2% +$14 ﹤0.01% 500
2021
Q3
$1K Buy
47
+1
+2% +$17 ﹤0.01% 487
2021
Q2
$1K Buy
46
+1
+2% +$18 ﹤0.01% 484
2021
Q1
$1K Hold
45
﹤0.01% 484
2020
Q4
$1K Buy
45
+1
+2% +$16 ﹤0.01% 410
2020
Q3
$1K Buy
44
+1
+2% +$15 ﹤0.01% 432
2020
Q2
$1K Hold
43
﹤0.01% 425
2020
Q1
$0 Hold
43
﹤0.01% 516
2019
Q4
$0 Hold
43
﹤0.01% 542
2019
Q3
$1K Hold
43
﹤0.01% 476
2019
Q2
$1K Buy
+43
New +$838 ﹤0.01% 494

Other funds holding SBRA

TimeScale Financial's SBRA Position: Q2 2023 in Review

TimeScale Financial increased its Sabra Healthcare REIT (SBRA) stake by 1.9% in Q2 2023, buying an estimated $11 and bringing the position to 55 shares worth $650. The position accounts for ﹤0.01% of the portfolio, ranked #563.

TimeScale Financial first reported a position in SBRA in Q2 2019 and has held it in 17 quarters since. The position peaked at $1K in Q3 2022. 325 funds tracked by Wall St. Rank hold SBRA as of Q2 2023.

  • TimeScale Financial held 55 shares of Sabra Healthcare REIT worth $650 as of Q2 2023.
  • TimeScale Financial bought 1 Sabra Healthcare REIT share in Q2 2023, an estimated $11.
  • Sabra Healthcare REIT made up ﹤0.01% of TimeScale Financial's portfolio in Q2 2023, its #563 holding.
  • TimeScale Financial first reported a position in Sabra Healthcare REIT in Q2 2019 and has held it in 17 quarters since.
  • TimeScale Financial's Sabra Healthcare REIT position peaked at $1K in Q3 2022.
  • 325 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.